₨ 9,000
Femara 2.5 mg is the brand name for the generic drug letrozole, a type of hormone therapy medication primarily used to treat certain types of breast cancer in women who have gone through menopause. It belongs to a class of drugs called aromatase inhibitors.
Key Information
Feature Detail Active Ingredient Letrozole 2.5 mg Manufacturer Novartis Class Aromatase inhibitor (hormone therapy) Form Film-coated tablets, taken orally Primary Use Treatment of hormone receptor-positive breast cancer in postmenopausal women Common Uses
- Early Breast Cancer: Used after surgery to lower the risk of the cancer returning.
- Extended Adjuvant Treatment: Prescribed for women who have completed five years of tamoxifen therapy to further reduce recurrence risk.
- Advanced Breast Cancer: Used to slow or stop the growth of cancer that has spread to nearby areas or other parts of the body.
- Infertility (Off-label): It is also widely used off-label to induce ovulation in women with conditions like polycystic ovary syndrome (PCOS) who are trying to conceive.
Common Side Effects
Side effects are often related to the reduction of estrogen in the body:
- Hot flashes and sweating
- Joint or muscle pain
- Fatigue and dizziness
- Headache
- Nausea
- Bone thinning (osteoporosis)
- Increased cholesterol levels
Always consult a healthcare professional for medical advice regarding this medication and its suitability for your condition.
₨ 10,000
